Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 50

References for PMC Articles for PubMed (Select 19113837)

1.

(-)-Epigallocatechin gallate induces Nrf2-mediated antioxidant enzyme expression via activation of PI3K and ERK in human mammary epithelial cells.

Na HK, Kim EH, Jung JH, Lee HH, Hyun JW, Surh YJ.

Arch Biochem Biophys. 2008 Aug 15;476(2):171-7. doi: 10.1016/j.abb.2008.04.003. Epub 2008 Apr 6.

PMID:
18424257
2.

Uncoupling by (--)-epigallocatechin-3-gallate of ATP-sensitive potassium channels from phosphatidylinositol polyphosphates and ATP.

Jin JY, Park SH, Bae JH, Cho HC, Lim JG, Park WS, Han J, Lee JH, Song DK.

Pharmacol Res. 2007 Sep;56(3):237-47. Epub 2007 Jun 21.

PMID:
17656102
3.

Direct inhibition of insulin-like growth factor-I receptor kinase activity by (-)-epigallocatechin-3-gallate regulates cell transformation.

Li M, He Z, Ermakova S, Zheng D, Tang F, Cho YY, Zhu F, Ma WY, Sham Y, Rogozin EA, Bode AM, Cao Y, Dong Z.

Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):598-605.

4.

Phase I and pharmacodynamic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with refractory advanced cancers.

Ramanathan RK, Egorin MJ, Eiseman JL, Ramalingam S, Friedland D, Agarwala SS, Ivy SP, Potter DM, Chatta G, Zuhowski EG, Stoller RG, Naret C, Guo J, Belani CP.

Clin Cancer Res. 2007 Mar 15;13(6):1769-74.

5.

(-)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78.

Ermakova SP, Kang BS, Choi BY, Choi HS, Schuster TF, Ma WY, Bode AM, Dong Z.

Cancer Res. 2006 Sep 15;66(18):9260-9.

6.
7.

Structure and mechanism of the Hsp90 molecular chaperone machinery.

Pearl LH, Prodromou C.

Annu Rev Biochem. 2006;75:271-94. Review.

PMID:
16756493
8.

A potential endogenous ligand for the aryl hydrocarbon receptor has potent agonist activity in vitro and in vivo.

Henry EC, Bemis JC, Henry O, Kende AS, Gasiewicz TA.

Arch Biochem Biophys. 2006 Jun 1;450(1):67-77. Epub 2006 Mar 3.

PMID:
16545771
9.

Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate.

Khan N, Afaq F, Saleem M, Ahmad N, Mukhtar H.

Cancer Res. 2006 Mar 1;66(5):2500-5. Review.

10.

Search for Hsp90 inhibitors with potential anticancer activity: isolation and SAR studies of radicicol and monocillin I from two plant-associated fungi of the Sonoran desert.

Turbyville TJ, Wijeratne EM, Liu MX, Burns AM, Seliga CJ, Luevano LA, David CL, Faeth SH, Whitesell L, Gunatilaka AA.

J Nat Prod. 2006 Feb;69(2):178-84.

11.

Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications.

Zaveri NT.

Life Sci. 2006 Mar 27;78(18):2073-80. Epub 2006 Jan 30. Review.

PMID:
16445946
13.
14.

Hsp90 inhibitor 17-AAG reduces ErbB2 levels and inhibits proliferation of the trastuzumab resistant breast tumor cell line JIMT-1.

Zsebik B, Citri A, Isola J, Yarden Y, Szöllosi J, Vereb G.

Immunol Lett. 2006 Apr 15;104(1-2):146-55. Epub 2005 Dec 12.

PMID:
16384610
15.

HSP90 protects apoptotic cleavage of vimentin in geldanamycin-induced apoptosis.

Zhang MH, Lee JS, Kim HJ, Jin DI, Kim JI, Lee KJ, Seo JS.

Mol Cell Biochem. 2006 Jan;281(1-2):111-21.

PMID:
16328963
16.

Constantly updated knowledge of Hsp90.

Terasawa K, Minami M, Minami Y.

J Biochem. 2005 Apr;137(4):443-7. Review.

PMID:
15858167
17.
18.

Functional specificity of co-chaperone interactions with Hsp90 client proteins.

Riggs DL, Cox MB, Cheung-Flynn J, Prapapanich V, Carrigan PE, Smith DF.

Crit Rev Biochem Mol Biol. 2004 Sep-Dec;39(5-6):279-95. Review.

PMID:
15763706
19.

The intermediate filament protein vimentin is a new target for epigallocatechin gallate.

Ermakova S, Choi BY, Choi HS, Kang BS, Bode AM, Dong Z.

J Biol Chem. 2005 Apr 29;280(17):16882-90. Epub 2005 Feb 15.

20.

Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement.

Henning SM, Niu Y, Lee NH, Thames GD, Minutti RR, Wang H, Go VL, Heber D.

Am J Clin Nutr. 2004 Dec;80(6):1558-64.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk